z-logo
open-access-imgOpen Access
Intranuclear Translocation Signaling of HB-EGF Carboxy-Terminal Fragment and Mucosal Defense through Cell Proliferation and Migration in Digestive Tracts
Author(s) -
Satoshi Tanida,
Hiromi Kataoka,
Tsutomu Mizoshita,
Takaya Shimura,
Toshio Kamiya,
Takashi Joh
Publication year - 2010
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000310903
Subject(s) - microbiology and biotechnology , heparin binding egf like growth factor , epidermal growth factor , biology , signal transduction , cell growth , autocrine signalling , receptor , biochemistry
Mucosal integrity in the digestive tracts is maintained by defense mechanisms which comprise mucin production, microcirculatory blood flow, intercellular junctions, cell growth and mucosal repair. These physiological features are known to be regulated by prostaglandins, nitric oxides, growth factors, and cytokines. Mucosal injury and inflammation occur when cytotoxic attacks overwhelm cellular capacity for defense or repair. Interleukin-8 (IL-8) promotes tumor cell proliferation in colon cancer cells after binding to its receptors, which are members of the G-protein-coupled receptor (GPCR) family. Stimulation of GPCR can induce shedding of epidermal growth factor (EGF) ligands via activation of A disintegrin and metalloprotease (ADAM), with subsequent transactivation of the EGF receptor (EGFR). In parallel with EGF signaling through EGFR activation, heparin-binding (HB)-EGF carboxy-terminal fragment (CTF) signaling is also involved in cell proliferation through nuclear export of promyelocytic leukemia zinc finger. IL-8 induces cell proliferation and migration by an ADAM-dependent intranuclear translocation pathway of HB-EGF-CTF. Here, we focus on the mechanisms of IL-8-induced HB-EGF-CTF signaling, which is involved in cytoprotection and cellular repair.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here